S Suryawanshi

The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial

Saud Al Sifri, A. Basiounny, Akram Echtay et al. · International Journal of Clinical Practice · 2011 · 105 citations · Full text

Medicine, Endocrinology, Pharmacology +11

A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

Louis J. Aronne, Serena Tonstad, Manuel Moreno et al. · International Journal of Obesity · 2010 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +11

Potent and Selective Agonism of the Melanocortin Receptor 4 With MK-0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy

Rajesh Krishna, Barry Gumbiner, C. Melinda Stevens et al. · Clinical Pharmacology & Therapeutics · 2009 · 87 citations

Medicine, Endocrinology, Pharmacology +17

A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

Joseph Proietto, A Rissanen, Joyce B. Harp et al. · International Journal of Obesity · 2010 · 67 citations

Medicine, Pharmacology, Pharmacotherapy +10

Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer

Dana E. Rathkopf, Manish R. Patel, Atish D. Choudhury et al. · Annals of Oncology · 2024 · 66 citations · Full text

Medicine, Oncology, Pharmacology +16